ATAD2 is a bromodomain-containing protein whose overexpression is linked to poor outcomes in a number of different cancer types. To date, no potent and selective inhibitors of the bromodomain have been reported. This article describes the structure-based optimization of a series of naphthyridones from micromolar leads with no selectivity over the BET bromodomains to inhibitors with sub-100 nM ATAD2 potency and 100-fold BET selectivity.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1021/acs.jmedchem.5b00773 | DOI Listing |
Publication Analysis
Top Keywords
structure-based optimization
8
optimization naphthyridones
4
naphthyridones potent
4
potent atad2
4
atad2 bromodomain
4
bromodomain inhibitors
4
inhibitors atad2
4
atad2 bromodomain-containing
4
bromodomain-containing protein
4
protein overexpression
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!